Capstone Investment Advisors, LLC Cti Biopharma Corp Transaction History

Capstone Investment Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.44 - $2.86 $72,640 - $144,272	-50,445 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.25 - $3.18 $113,501 - $160,415	50,445 New	50,445 $148,000
Q1 2021 May 17, 2021	SELL	$2.68 - $3.8 $74,423 - $105,526	-27,770 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.48 - $3.8 $68,869 - $105,526	27,770 New	27,770 $89,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Investment Advisors, LLC with notifications on news.